BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1551 related articles for article (PubMed ID: 17457343)

  • 1. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling adaptors used by Toll-like receptors: an update.
    Kenny EF; O'Neill LA
    Cytokine; 2008 Sep; 43(3):342-9. PubMed ID: 18706831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.
    Sheedy FJ; O'Neill LA
    J Leukoc Biol; 2007 Aug; 82(2):196-203. PubMed ID: 17449723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
    McGettrick AF; O'Neill LA
    Mol Immunol; 2004 Jul; 41(6-7):577-82. PubMed ID: 15219996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
    Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
    Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARM inhibits both TRIF- and MyD88-mediated AP-1 activation.
    Peng J; Yuan Q; Lin B; Panneerselvam P; Wang X; Luan XL; Lim SK; Leung BP; Ho B; Ding JL
    Eur J Immunol; 2010 Jun; 40(6):1738-47. PubMed ID: 20306472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPPIT analysis of early Toll-like receptor signalling events.
    Ulrichts P; Tavernier J
    Immunol Lett; 2008 Mar; 116(2):141-8. PubMed ID: 18221795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIR-containing adaptors in Toll-like receptor signalling.
    Jenkins KA; Mansell A
    Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like.
    Siednienko J; Halle A; Nagpal K; Golenbock DT; Miggin SM
    Eur J Immunol; 2010 Nov; 40(11):3150-60. PubMed ID: 20957750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signalling of toll-like receptors.
    Brikos C; O'Neill LA
    Handb Exp Pharmacol; 2008; (183):21-50. PubMed ID: 18071653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
    Carlsson E; Ding JL; Byrne B
    Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.
    O'Neill LA; Dunne A; Edjeback M; Gray P; Jefferies C; Wietek C
    J Endotoxin Res; 2003; 9(1):55-9. PubMed ID: 12691620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of four TIR domain-containing adaptors, MyD88, TRIF, MAL, and SARM in mandarin fish Siniperca chuatsi.
    Wang KL; Chen SN; Li L; Huo HJ; Nie P
    Dev Comp Immunol; 2021 Sep; 122():104110. PubMed ID: 33933533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection.
    Fischer H; Yamamoto M; Akira S; Beutler B; Svanborg C
    Eur J Immunol; 2006 Feb; 36(2):267-77. PubMed ID: 16385628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
    Hardy MP; McGGettrick AF; O'Neill LA
    Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4.
    Pålsson-McDermott EM; O'Neill LA
    Immunology; 2004 Oct; 113(2):153-62. PubMed ID: 15379975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 78.